Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global

October 2013 | 277 pages | ID: C8E3E14B33CEN
Renub Research

Abstracts

Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria combined. Cancer testing has tremendous growth opportunities for the next five years. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Accordingly, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The global cancer test market is expected to be more than US$ 14 Billion by 2018.

Renub Research study titled “Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This 277 page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters.

A. Global – Cancer Testing Market and New Cases (Chapter 2)
B. Global – Cancer Testing Market Share & Forecast (Chapter 3)
C. Global – Segment Wise Cancer Testing Market & Forecast (Chapter 4)
D. Global – Organ Specific Cancer Testing Market & Forecast (Chapter 5)
E. Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter 6)
F. Geographic Region – Number of New Cancer Cases (Chapter 7)
G. Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials (Chapter 8)

Global – Segment Wise Cancer Testing Market (To 2018) (Chapter No. 4)

• Prostate Specific Antigen (PSA) Test Market & Forecast
• Fecal Occult Blood Test Market & Forecast
• Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast
• Human Papilloma Virus (HPV) Test Market & Forecast
• Bladder Test Market & Forecast
• Serum Based Cancer Markers Market & Forecast
• Pharmacognostic Histology Market & Forecast
• Flow Cytometry Market & Forecast
• Other Test Market & Forecast

Global – Organ Specific Cancer Testing Market (To 2018) (Chapter No. 5)

• Bladder Cancer Test Market & Forecast
• Breast Cancer Test Market & Forecast
• Cervical Cancer Test Market & Forecast
• Colorectal (Colon) Cancer Test Market & Forecast
• Ovarian Cancer Test Market & Forecast
• Prostate Cancer Test Market & Forecast
• Liver Cancer Test Market & Forecast
• Flow Cytometry Market & Forecast
• Other Organ Specific Cancer Test Market & Forecast

Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter No. 6)

1. Abbott 11 Genomic Health Inc
2. Radient Pharmaceuticals 12 QIAGEN Marseille (Earlier Ipsogen)
3. BD Diagnostics 13 Myriad Genetics, Inc
4. Beckman Coulter, Inc. 14 Panacea Pharmaceuticals, Inc.
5. BioCurex 15 Qiagen
6. bioMerieux 16 Siemens Heathcare Diagnostics
7. Cepheid 17 Roche
8. CytoCore Inc. 18 Ventana Medical Systems
9. DiagnoCure, Inc 19 Trovagene Inc
10. Gen-Probe, Inc. 20 Vermillion, Inc

Geographic Region – Number of New Cancer Cases (To 2020) (Chapter No. 7)

1. Africa
2. Americas
3. Asia
4. Europe
5. Oceania

Number of New Cancer Cases by Site - Geographic Region Distribution (To 2020) (Chapter 8)

1. Bladder Cancer 15 Myeloma
2. Brain Cancer 16 Nasopharynx
3. Breast Cancer 17 Non-Hodgkin Lymphoma
4. Cervix Cancer 18 Oesophagus
5. Colorectal Cancer 19 Oral Cavity
6. Corpus Cancer 20 Other Pharynx
7. Hodgkin’s Lymphoma 21 Ovary Cancer
8. Kaposi Sarcoma 22 Pancreas Cancer
9. Kidney Cancer 23 Prostate Cancer
10. Larynx Cancer 24 Stomach Cancer
11. Leukaemia 25 Testis Cancer
12. Liver Cancer 26 Thyroid Cancer
13. Lung Cancer 27 Other Sites
14. Melanoma

Cancer Site - Clinical Trials (Chapter 8)

1. Bladder Cancer
2. Cervical Cancer
3. Colorectal Cancer
4. Liver Cancer
5. Ovarian Cancer
6. Prostate Cancer

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL – CANCER TESTING MARKET AND NEW CASES

2.1 Global – Cancer Testing Market (2010 – 2018)
2.2 Global – Number of New Cancer Cases (2009 – 2020)

3. GLOBAL – CANCER TESTING MARKET SHARE

3.1 Global – Segment Wise Cancer Testing Market Share& Forecast (2011 – 2018)
3.2 Global – Organ Specific Cancer Testing Market Share & Forecast (2010 – 2018)

4. GLOBAL – SEGMENT WISE CANCER TESTING MARKET

4.1 Prostate Specific Antigen (PSA) Test Market & Forecast (2010 – 2018)
4.2 Fecal Occult Blood Test Market & Forecast (2009 – 2018)
4.3 Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast (2010 – 2018)
4.4 Human PapillomaVirus (HPV) Test Market & Forecast (2010 – 2018)
4.5 Bladder Test Market & Forecast (2010 – 2018)
4.6 Serum Based Cancer Markers Market & Forecast (2008 – 2018)
4.7 Pharmacognostic Histology Market & Forecast (2011 – 2018)
4.8 Flow Cytometry Market & Forecast (2011 – 2018)
4.9 Other Test Market& Forecast (2011 – 2018)

5. GLOBAL – ORGAN SPECIFIC CANCER TESTING MARKET

5.1 Bladder Cancer Test Market& Forecast (2010 – 2018)
5.2 Breast Cancer Test Market & Forecast (2010 – 2018)
5.3 Cervical Cancer Test Market & Forecast (2010 – 2018)
5.4 Colorectal (Colon) Cancer Test Market & Forecast (2010 – 2018)
5.5 Ovarian Cancer Test Market & Forecast (2010 – 2018)
5.6 Prostate Cancer Test Market & Forecast (2010 – 2018)
5.7 Liver Cancer Test Market & Forecast (2010 – 2018)
5.8 Other Organ Specific Cancer Test Market & Forecast (2010 – 2018)

6. CANCER DIAGNOSTICS– COMPANIES NOVEL TEST PLATFORMS & PIPELINE ANALYSIS (20 COMPANIES ANALYSIS)

6.1 Abbott
  6.1.1 Abbott – Cancer Test Platforms
  6.1.2 Abbott's Cancer Pipeline Analysis
6.2 Radient Pharmaceuticals
  6.2.1 Radient Pharmaceuticals – Cancer Test Platforms
6.3 BD Diagnostics
  6.3.1 BD Diagnostics – Cancer Test Platform
  6.3.2 BD Diagnostics Pipeline Analysis
6.4 Beckman Coulter, Inc.
  6.4.1 Beckman Coulter, Inc. – Cancer Test platform
6.5 BioCurex
  6.5.1 BioCurex – Cancer Test Platform
  6.5.2 BioCurex – Pipeline Analysis
6.6 bioMerieux
  6.6.1 bioMerieux – Cancer Test Platform
  6.6.2 bioMérieux - Pipeline Analysis
6.7 Cepheid
  6.7.1 Cepheid – Cancer Test Platform
  6.7.2 Cepheid – Pipeline Analysis
6.8 CytoCore Inc.
  6.8.1 CytoCore Inc. – Cancer Test Platform
  6.8.2 CytoCore Inc. – Pipeline Analysis
6.9 DiagnoCure, Inc.
  6.9.1 DiagnoCure, Inc. – Cancer Test Platform
  6.9.2 DiagnoCure Inc. – Pipeline Analysis
6.10 Gen-Probe, Inc.
  6.10.1 Gen-Probe, Inc. – Cancer Test Platform
6.11 Genomic Health Inc.
  6.11.1 Genomic Health Inc. – Cancer Test Platform
  6.11.2 GenomicHealth, Inc. – Pipeline Analysis
6.12 QIAGEN Marseille (Earlier Ipsogen)
  6.12.1 QIAGEN Marseille – Cancer Test Platform
6.13 Myriad Genetics, Inc
  6.13.1 Myriad Genetics, Inc – Cancer Test Platform
  6.13.2 Myriad Genetics, Inc – Pipeline Analysis
6.14 Panacea Pharmaceuticals, Inc.
  6.14.1 Panacea Pharmaceuticals, Inc. – Cancer Test Platform
6.15 Qiagen
  6.15.1 Qiagen – Cancer Test Platform
  6.15.2 Qiagen – Pipeline Analysis
6.16 Siemens Heathcare Diagnostics
  6.16.1 Siemens Heathcare Diagnostics – Cancer Test Platform
6.17 Roche
  6.17.1 Roche – Cancer Test Platform
  6.17.2 Roche – Pipeline Analysis
6.18 Ventana Medical Systems, Inc.
  6.18.1 Ventana Medical Systems, Inc. – Cancer Test Platform
6.19 TrovageneInc.
  6.19.1 Trovagene, Inc. – Cancer Test Platform
  6.19.2 TrovageneInc. – Pipeline Analysis
6.20 Vermillion, Inc
  6.20.1 Vermillion, Inc – Cancer Test Platform

7. GEOGRAPHIC REGION – NUMBER OF NEW CANCER CASES

7.1 Africa – Number of New Cancer Cases & Forecast (2009 – 2020)
7.2 Americas – Number of New Cancer Cases & Forecast (2009 – 2020)
7.3 Asia – Number of New Cancer Cases & Forecast (2009 – 2020)
7.4 Europe – Number of New Cancer Cases & Forecast (2009 – 2020)
7.5 Oceania – Number of New Cancer Cases & Forecast (2009 – 2020)

8. NUMBER OF NEW CANCER CASES BY SITE - GEOGRAPHIC REGION DISTRIBUTION & CLINICAL TRIALS

8.1 Bladder Cancer Number of New Cases & Clinical Trials
  8.1.1 Bladder Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
  8.1.2 Bladder Cancer – Tests Being Studied in Clinical Trials
8.2 Brain Cancer Number of New Cases
  8.2.1 Brain Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.3 Breast Cancer Number of New Cases
  8.3.1 Breast Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.4 Cervix Cancer Number of New Cases & Clinical Trials
  8.4.1 Cervix Cancer Number of New Cases & Forecast – Geographic Distribution (2009 -2020)
  8.4.2 Cervical Cancer – Test Being Studied in Clinical Trials
8.5 Colorectal Cancer Number of New Cases & Clinical Trials
  8.5.1 Colorectal Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
  8.5.2 Colorectal Cancer – Test Being Studied in Clinical Trials
8.6 Corpus Cancer Number of New Cases
  8.6.1 Corpus Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.7 Hodgkin’s Lymphoma Number of New Cases
  8.7.1 Hodgkin’s Lymphoma Number of New Cases & Forecast – Geographic Distribution (2009 -2020)
8.8 Kaposi Sarcoma Number of New Cases
  8.8.1 Kaposi Sarcoma Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.9 Kidney Cancer Number of New Cases
  8.9.1 Kidney Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.10 Larynx Cancer Number of New Cases
  8.10.1 Larynx Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.11 Leukaemia Number of New Cases
  8.11.1 Leukaemia Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.12 Liver Cancer Number of New Cases & Clinical Trials
  8.12.1 Liver Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
  8.12.2 Liver Cancer – Test Being Studied in Clinical Trials
8.13 Lung Cancer Number of New Cases
  8.13.1 Lung Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.14 Melanoma Number of New Cases
  8.14.1 Melanoma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.15 Myeloma Number of New Cases
  8.15.1 Myeloma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.16 Nasopharynx Number of New Cases
  8.16.1 Nasopharynx Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.17 Non-Hodgkin Lymphoma Number of New Cases
  8.17.1 Non-Hodgkin Lymphoma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.18 Oesophagus Number of New Cases
  8.18.1 Oesophagus Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.19 Oral Cavity Number of New Cases
  8.19.1 Oral Cavity Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.20 Other Pharynx Number of New Cases
  8.20.1 Other Pharynx Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.21 Ovary Cancer Number of New Cases & Clinical Trials
  8.21.1 Ovary Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
  8.21.2 Ovarian Cancer – Tests Being Studied In Clinical Trials
8.22 Pancreas Cancer Number of New Cases
  8.22.1 Pancreas Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.23 Prostate Cancer Number of New Cases & Clinical Trials
  8.23.1 Prostate Cancer Number of New Cases & Forecast – Geographic Distribution (2009 -2020)
  8.23.2 Prostate Cancer – Test Being Studied in Clinical Trials
8.24 Stomach Cancer Number of New Cases
  8.24.1 Stomach Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.25 Testis Cancer Number of New Cases
  8.25.1 Testis Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.26 Thyroid Cancer Number of New Cases
  8.26.1 Thyroid Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020)
8.27 Other Sites – Number of New Cases

List Of Figures

LIST OF FIGURES

Figure 2 1: Global – Cancer Test Market (Million US$), 2010 – 2012
Figure 2 2: Global – Forecast for Cancer Test Market (Million US$), 2013 – 2018
Figure 2 3: Global – Number of New Cancer Cases (Number), 2009 – 2012
Figure 2 4: Global – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
Figure 3 1: Global – Segment Wise Cancer Test Market Share (Percent), 2011 – 2012
Figure 3 2: Global – Forecast for Segment Wise Cancer Test Market Share (Percent), 2013 – 2018
Figure 3 3: Global – Organ Specific Cancer Testing Market Share (Percent), 2010 – 2012
Figure 3 4: Global – Forecast for Organ Specific Cancer Testing Market Share (Percent), 2013 – 2018
Figure 4 1: Global – PSA Test Market (Million US$), 2010 –2012
Figure 4 2: Global – Forecast for PSA Test Market (Million US$), 2013 –2018
Figure 4 3: Global – Fecal Occult Blood Test Market (Million US$), 2009 –2012
Figure 4 4: Global – Forecast for Occult Blood Test Market (Million US$), 2013 –2018
Figure 4 5: Global – FISH Test Market (Million US$), 2010 – 2012
Figure 4 6: Global – Forecast for FISH Test Market (Million US$), 2013 – 2018
Figure 4 7: Global – HPV Test Market (Million US$), 2010 – 2012
Figure 4 8: Global – Forecast for HPV Test Market (Million US$), 2013 – 2018
Figure 4 9: Global – Bladder Cancer Test Market (Million US$), 2010 – 2012
Figure 4 10: Global – Forecast for Bladder Test Market (Million US$), 2013 – 2018
Figure 4 11: Global – Serum Based Cancer Markers Market (Million US$), 2008 – 2012
Figure 4 12: Global – Forecast for Serum Based Cancer Markers Market (Million US$), 2013 – 2018
Figure 4 13: Global – Pharmacognostic Histology Market (Million US$), 2011 – 2012
Figure 4 14: Global – Forecast for Pharmacognostic Histology Market (Million US$), 2013 – 2018
Figure 4 15: Global – Flow Cytometry Market (Million US$), 2011 – 2012
Figure 4 16: Global – Forecast for Flow Cytometry Market (Million US$), 2013 – 2018
Figure 4 17: Global – Other Test Market (Million US$), 2011 – 2012
Figure 4 18: Global – Forecast for Other Test Market (Million US$), 2013 – 2018
Figure 5 1: Global – Bladder Cancer Test Market (Million US$), 2010 – 2012
Figure 5 2: Global – Forecast for Bladder Cancer Test Market (Million US$), 2013 – 2018
Figure 5 3: Global – Breast Cancer Test Market (Million US$), 2010 – 2013
Figure 5 4: Global – Forecast for Breast Cancer Test Market (Million US$), 2013 – 2018
Figure 5 5: Global – Cervical Cancer Test Market (Million US$), 2010 – 2012
Figure 5 6: Global – Forecast for Cervical Cancer Test Market (Million US$), 2013 – 2018
Figure 5 7: Global – Colorectal (Colon) Cancer Test Market (Million US$), 2010 – 2012
Figure 5 8: Global – Forecast for Colorectal (Colon) Cancer Test Market (Million US$), 2013 – 2018
Figure 5 9: Global – Ovarian Cancer Test Market (Million US$), 2010 – 2012
Figure 5 10: Global – Forecast for Ovarian Cancer Test Market (Million US$), 2013 – 2018
Figure 5 11: Global – Prostate Cancer Test Market (Million US$), 2010 – 2012
Figure 5 12: Global – Forecast for Prostate Cancer Test Market (Million US$), 2013 – 2018
Figure 5 13: Global – Liver Cancer Test Market (Million US$), 2010 – 2012
Figure 5 14: Global – Forecast for Liver Cancer Test Market (Million US$), 2013 – 2018
Figure 5 15: Global – Other Organ Cancer Test Market (Million US$), 2010 – 2012
Figure 5 16: Global – Forecast for Other Organ Cancer Test Market (Million US$), 2013 – 2018
Figure 7 1: Africa –Number of New Cancer Cases (Number), 2009 – 2012
Figure 7 2: Africa – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
Figure 7 3: Americas –Number of New Cancer Cases (Number), 2009 – 2012
Figure 7 4: Americas – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
Figure 7 5: Asia –Number of New Cancer Cases (Number), 2009 – 2012
Figure 7 6: Asia – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
Figure 7 7: Europe – Number of New Cancer Cases (Number), 2009 – 2012
Figure 7 8: Europe – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
Figure 7 9: Oceania –Number of New Cancer Cases (Number), 2009 – 2012
Figure 7 10: Oceania – Forecast for Number of New Cancer Cases (Number), 2013 – 2020

List Of Tables

LIST OF TABLES

Table 6 1: Effectiveness of Onko-Sure Within Different Cancer Types
Table 6 2: Beckman Coulter – Flow Cytometry Technology portfolio and Various Bundling Options
Table 6 3: Beckman Coulter – Hematology Test Product portfolio
Table 6 4: bioMérieux – Tumor Markers offerings for Various Cancer
Table 8 1: Bladder– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 2: Bladder– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 3: Brain– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 4: Brain– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 5: Breast – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 6: Breast– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 7: Cervix– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 8: Cervix– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 9: Colorectal– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 10: Colorectal– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 11: Corpus– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 12: Corpus– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 13: Hodgkin’s Lymphoma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 14: Hodgkin’s Lymphoma – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 15: Kaposi Sarcoma – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 16: Kaposi Sarcoma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 17: Kidney– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 18: Kidney– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 19: Larynx– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 20: Larynx– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 21: Leukaemia – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 22: Leukaemia– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 23: Liver – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 24: Liver– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 25: Lung – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 26: Lung– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 27: Melanoma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 28: Melanoma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 29: Myeloma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 30: Myeloma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 31: Nasopharynx – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 32: Nasopharynx– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 33: Non-Hodgkin Lymphoma – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 34: Non-Hodgkin Lymphoma – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 35: Oesophagus – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 36: Oesophagus – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 37: Oral Cavity– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 38: Oral Cavity – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 39: Other Pharynx – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 40: Other Pharynx – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 41: Ovary – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 42: Ovary – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 43: Pancreas – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 44: Pancreas – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 45: Prostate – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 46: Prostate – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 47: Stomach – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 48: Stomach – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 49: Testis – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 50: Testis – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 51: Thyroid – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 52: Thyroid – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 53: Other Sites – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 54: Other Sites – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020